Topographical overlap of β-amyloid deposition in patients with Alzheimer's disease and mild cognitive impairment - a voxel-wise [18F]Florbetapir PET/CT study

被引：0
|
作者：
Aghakhanyan, G. [1 ]
Gennaro, M. [1 ]
Mazzarri, S. [1 ]
Vergallo, A. [2 ]
Nicoletti, V. [2 ]
Cintoli, S. [2 ]
Manca, G. [1 ]
Garau, L. [1 ]
De Laurentis, G. [1 ]
Spinelli, E. [1 ]
Bala, S. [1 ]
Grosso, M. [1 ]
Radicchi, C. [2 ]
Tognoni, G. [2 ]
Bonuccelli, U. [2 ]
Volterrani, D. [1 ]
机构：
[1] Univ Hosp Pisa, Reg Ctr Nucl Med, Pisa, Italy
[2] Univ Pisa, Dept Clin & Expt Med, Unit Neurol, Pisa, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0384
引用
收藏
页码：S593 / S594
页数：2
相关论文
共 50 条
  • [1] Imaging characteristics and safety of florbetapir (18F) in Japanese healthy volunteers, patients with mild cognitive impairment and patients with Alzheimer's disease
    Namiki, Chihiro
    Takita, Yasushi
    Iwata, Atsushi
    Momose, Toshimitsu
    Senda, Michio
    Okubo, Yoshiro
    Joshi, Abhinay D.
    Lu, Ming
    Agbulos, Abigail
    Breault, Christopher
    Pontecorvo, Michael J.
    [J]. ANNALS OF NUCLEAR MEDICINE, 2015, 29 (07) : 570 - 581
  • [2] Clinical impact of amyloid PET using 18F-florbetapir in patients with cognitive impairment and suspected Alzheimer's disease: a multicenter study
    Matsuda, Hiroshi
    Okita, Kyoji
    Motoi, Yumiko
    Mizuno, Toshiki
    Ikeda, Manabu
    Sanjo, Nobuo
    Murakami, Koji
    Kambe, Taiki
    Takayama, Toshiki
    Yamada, Kei
    Suehiro, Takashi
    Matsunaga, Keiko
    Yokota, Takanori
    Tateishi, Ukihide
    Shigemoto, Yoko
    Kimura, Yukio
    Chiba, Emiko
    Kawashima, Takahiro
    Tomo, Yui
    Tachimori, Hisateru
    Kimura, Yuichi
    Sato, Noriko
    [J]. ANNALS OF NUCLEAR MEDICINE, 2022, 36 (12) : 1039 - 1049
  • [3] Clinical impact of amyloid PET using 18F-florbetapir in patients with cognitive impairment and suspected Alzheimer’s disease: a multicenter study
    Hiroshi Matsuda
    Kyoji Okita
    Yumiko Motoi
    Toshiki Mizuno
    Manabu Ikeda
    Nobuo Sanjo
    Koji Murakami
    Taiki Kambe
    Toshiki Takayama
    Kei Yamada
    Takashi Suehiro
    Keiko Matsunaga
    Takanori Yokota
    Ukihide Tateishi
    Yoko Shigemoto
    Yukio Kimura
    Emiko Chiba
    Takahiro Kawashima
    Yui Tomo
    Hisateru Tachimori
    Yuichi Kimura
    Noriko Sato
    [J]. Annals of Nuclear Medicine, 2022, 36 : 1039 - 1049
  • [4] Imaging characteristics and safety of florbetapir (18F) in Japanese healthy volunteers, patients with mild cognitive impairment and patients with Alzheimer’s disease
    Chihiro Namiki
    Yasushi Takita
    Atsushi Iwata
    Toshimitsu Momose
    Michio Senda
    Yoshiro Okubo
    Abhinay D. Joshi
    Ming Lu
    Abigail Agbulos
    Christopher Breault
    Michael J. Pontecorvo
    [J]. Annals of Nuclear Medicine, 2015, 29 : 570 - 581
  • [5] Role of [18F]FDG and [18F]Florbetapir PET/CT to predict Alzheimer's disease development in patients with Down syndrome
    Abouzian, S.
    Valverde, R.
    Pegueroles, J.
    Sizova, M.
    Fuentes, F.
    Fernandez, A.
    Duch, J.
    Lopez-Mora, D.
    Estorch, M.
    Barroeta, I.
    Carmona-Iragui, M.
    Lleo, A.
    Carrio, I.
    Flotats, A.
    Fortea, J.
    Camacho, V.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S297 - S297
  • [6] Prognosis of conversion of mild cognitive impairment to Alzheimer's dementia by voxel-wise Cox regression of FDG PET scans
    Sorensen, Arnd
    Blazhenets, Ganna
    Racker, Gerta
    Schiller, Florian
    Meyer, Philipp
    Frings, Lars
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [7] [18F]-Florbetapir PET in Alzheimer's Disease and Frontotemporal Dementia
    Langheinrich, Tobias C.
    Kobylecki, Christopher
    Hinz, Rainer
    Vardy, Emma R.
    Casado, Maria E. Martino
    Schmidt, Cathleen
    Richardson, Anna M.
    Snowden, Julie
    Rodriguez, Jose Anton
    Neary, David
    Mann, David D.
    Gerhard, Alex
    Herholz, Karl
    [J]. ANNALS OF NEUROLOGY, 2013, 74 : S89 - S90
  • [8] Effect of APOE ε4 Status on Brain Amyloid-β and Cognitive Function in Amnestic and Nonamnestic Mild Cognitive Impairment: A [18F] Florbetapir PET-CT Study
    Wang, Mengjie
    Zhang, Zhengwei
    Wang, Ying
    Huang, Lin
    Huang, Qi
    Ren, Shuhua
    Qian, Luojun
    Ni, Ruiqing
    Guo, Qihao
    Guan, Yihui
    Xie, Fang
    [J]. ADVANCED THERAPEUTICS, 2024, 7 (08)
  • [9] 18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage
    Silvia Morbelli
    Matteo Bauckneht
    Dario Arnaldi
    Agnese Picco
    Matteo Pardini
    Andrea Brugnolo
    Ambra Buschiazzo
    Marco Pagani
    Nicola Girtler
    Alberto Nieri
    Andrea Chincarini
    Fabrizio De Carli
    Gianmario Sambuceti
    Flavio Nobili
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 2073 - 2083
  • [10] A distinct [18F]MPPF PET profile in amnestic mild cognitive impairment compared to mild Alzheimer's disease
    Truchot, L.
    Costes, N.
    Zimmer, L.
    Laurent, B.
    Le Bars, D.
    Thomas-Anterion, C.
    Mercier, B.
    Hermier, M.
    Vighetto, A.
    Krolak-Salmon, P.
    [J]. NEUROIMAGE, 2008, 40 (03) : 1251 - 1256
12345